sever
ctype
lectin
receptor
famili
member
directli
implic
viral
uptak
dcsign
lsign
shown
interact
ebola
viru
hiv
well
receptor
also
shown
express
lsec
bind
glycoprotein
hepat
c
viru
hcv
facilit
hepatocyt
lsectin
also
implic
uptak
sever
acut
respiratori
syndrom
coronaviru
abil
lsec
bind
multipl
virus
divers
endocyt
receptor
give
crucial
role
respons
viral
infect
specif
role
mediat
rapid
clearanc
bloodborn
mous
model
adenoviru
infect
viru
found
lsec
found
kc
within
minut
intraven
viral
studi
publish
report
hivlik
particl
taken
mous
lsec
rate
million
particl
per
receptormedi
endocytosi
circul
matrix
breakdown
product
subsequ
transit
earli
endosom
late
endosom
take
sever
transit
virus
intern
lsec
less
well
understood
lsec
enabl
direct
entri
certain
virus
ebola
wherea
virus
hcv
hbv
lsec
promot
hepatotrop
facilit
parenchym
cell
rapid
uptak
viru
also
lead
redistribut
cell
instanc
anim
model
hbv
viral
particl
preferenti
taken
lsec
subsequ
pass
infect
underli
case
hcv
innat
sens
viral
infect
lsec
lead
downstream
signal
releas
paracrin
signal
provir
molecul
bone
morphogenet
protein
increas
viral
infect
hand
direct
sens
hcv
rna
lsec
also
lead
releas
type
type
iii
interferonrich
exosom
inhibit
hcv
balanc
respons
determin
whether
viru
infect
establish
prevent
therebi
emphas
critic
role
lsec
play
hepatotrop
viral
infect
lsec
regul
innat
immun
respons
also
directli
regul
adapt
immun
respons
antigen
present
cell
fig
knoll
group
demonstr
lsec
crosspres
antigen
use
scaveng
receptor
notabl
mannos
receptor
take
process
transfer
antigen
major
histocompat
complex
mhc
class
present
antigen
includ
oral
antigen
lsec
drive
tolerogen
respons
naiv
cell
mediat
upregul
lsec
coinhibitori
molecul
program
cell
death
ligand
activ
receptor
program
cell
death
protein
naiv
endocytosi
antigen
mannos
receptor
lsec
shown
promot
cell
includ
toler
tumour
howev
crucial
rapid
effector
respons
gener
local
harm
pathogen
consist
lsecdriven
cell
activ
chang
respons
antigen
load
local
inflammatori
factor
exampl
cultur
model
mous
lsec
antigen
vari
concentr
deliv
lsec
cross
present
cell
high
antigen
concentr
led
shift
tolerogen
effector
cell
consequ
enhanc
cell
receptor
tcr
signal
overcam
tolerogen
respons
respons
also
affect
local
level
furthermor
rapid
activ
cell
lsec
occur
presenc
transsignal
activ
drive
rapid
effector
cell
differenti
also
prime
cell
respond
inflammatori
signal
lead
sustain
effector
lsec
also
express
mhc
class
ii
molecul
enabl
present
antigen
howev
low
level
costimulatori
molecul
lsec
mean
rather
drive
naiv
cell
differenti
helper
promot
develop
regulatori
vivo
studi
shown
tolerogen
properti
lsec
control
autoimmun
circul
inflammatori
cell
helper
cell
cell
shown
interact
repeatedli
liver
sinusoid
endothelium
interact
success
suppress
inflammatori
cytokin
releas
induct
autoantigenspecif
regulatori
cell
lsec
also
shown
import
system
effect
amelior
damag
mous
model
autoimmun
central
nervou
system
find
therapeut
implic
system
well
local
immun
led
develop
nanotechnologybas
strategi
deliv
autoantigen
lsec
part
toler
induct
ctype
lectin
also
contribut
uniqu
abil
lsec
control
cell
differenti
thu
lsectin
lsec
inhibit
cell
activ
effector
function
interact
activ
convent
endotheli
adhes
molecul
mediat
firm
adhes
leukocyt
intercellular
adhes
molecul
vascular
cell
adhes
molecul
express
high
level
inflam
role
lymphocyt
recruit
liver
confirm
vitro
vivo
assay
bind
integrin
express
lymphocyt
import
role
captur
lymphocyt
blood
flow
mediat
bind
integrin
support
firm
adhes
within
hepat
anoth
famili
member
mucos
vascular
addressin
cell
adhes
molecul
bind
integrin
play
major
part
lymphocyt
home
gut
via
mucos
group
demonstr
receptor
also
upregul
liver
chronic
liver
diseas
promot
recruit
cell
activ
gut
express
high
level
integrin
therebi
contribut
link
ibd
inflammatori
liver
although
mani
immunoglobulin
superfamili
member
regul
proinflammatori
cytokin
adhes
function
also
depend
format
cell
surfac
platform
regul
tetraspanin
famili
receptor
form
microdomain
associ
later
exampl
group
confirm
associ
lsec
regul
lymphocyt
adhes
shear
addit
convent
adhes
molecul
group
other
demonstr
lsec
use
atyp
adhes
molecul
regul
leukocyt
recruit
vascular
adhes
protein
also
known
membranebound
amin
oxidas
origin
shown
mediat
lymphocyt
bind
high
endotheli
venul
special
postcapillari
venul
found
lymph
studi
confirm
express
high
level
chronic
liver
diseas
mediat
adhes
transmigr
across
model
vitro
vivo
inflammatori
liver
injuri
corrobor
role
mediat
recruit
liver
inflamm
uniqu
properti
gener
enzym
activ
upregul
express
adhes
molecul
chemokin
lsec
therebi
amplifi
leukocyt
scaveng
receptor
famili
endotheli
receptor
also
contribut
leukocyt
recruit
liver
stabilin
shown
regul
lymphocyt
adhes
lsec
via
integrin
homologu
stabilin
origin
shown
mediat
recruit
across
lymphat
similarli
express
stabilin
upregul
chronic
liver
diseas
hepatocellular
carcinoma
mediat
transmigr
lymphocyt
across
lsec
shear
follow
adher
leukocyt
crawl
across
endotheli
surfac
undergo
transmigr
usual
occur
via
endotheli
junction
term
paracellular
sever
studi
demonstr
lymphocyt
interact
lsec
within
sinusoid
trigger
import
immun
effector
might
influenc
infiltr
posit
cell
within
liver
inflammatori
liver
thu
import
understand
process
transendotheli
migrat
lsec
regul
visual
process
use
confoc
imag
lymphocyt
migrat
across
lsec
shear
stress
demonstr
cell
took
transcellular
rout
migrat
migrat
directli
endotheli
oppos
convent
paracellular
rout
transcellular
migrat
rout
involv
format
channel
facilit
lymphocyt
migrat
although
transcellular
migrat
note
special
endotheli
bed
function
molecular
basi
remain
poorli
transendotheli
migrat
multistep
process
involv
differ
combin
receptor
enabl
preferenti
recruit
particular
leukocyt
subset
describ
follow
section
addit
step
migrat
describ
lymphocyt
migrat
lsec
crawl
within
endotheli
cell
cell
junction
enter
adjac
endotheli
process
term
intracellular
crawl
depend
could
detect
lsec
stimul
interferon
famili
cytokin
treatment
alter
cytoskeleton
lsec
might
promot
intracellular
crawl
process
also
facilit
uniqu
junction
complex
lsec
function
consequ
intracellular
crawl
yet
elucid
could
import
role
lymphocyt
posit
liver
tissu
chemokin
famili
small
secret
protein
rang
amino
acid
size
bind
heparin
sulfat
play
central
part
leukocyt
migrat
homeostasi
develop
local
secondari
lymphoid
organ
well
within
tissu
inflammatori
respons
bind
g
proteincoupl
receptor
surfac
leukocyt
upregul
sever
chemokin
liver
vasculatur
demonstr
rang
chronic
inflammatori
liver
diseas
includ
alcohol
liver
diseas
primari
scleros
cholang
chronic
graft
condit
chemokin
seem
compartment
sinusoid
vasculatur
portal
vessel
substanti
influenc
immun
cell
local
subsequ
diseas
cell
migrat
across
sinusoid
endothelium
mediat
interferoninduc
chemokin
cxcchemokin
ligand
particularli
bind
receptor
cxcchemokin
receptor
diseas
includ
chronic
hcv
infect
chemokin
exist
transmembran
form
express
sinusoid
endothelium
hepatocyt
bile
duct
enabl
regul
recruit
retent
effector
cell
within
subset
natur
killer
nk
nk
cell
express
high
level
enabl
interact
sinusoid
endothelium
interact
promot
activ
migrat
along
sinusoid
part
process
ongo
immun
surveil
studi
mous
liver
endotheli
cell
shown
vital
properti
chemokinemedi
recruit
transcytosi
chemokin
basolater
side
lumin
side
sinusoid
endotheli
process
clathrindepend
promot
transendotheli
migrat
lymphocyt
across
lsec
inhibit
pathway
reduc
cell
recruit
liver
helper
cell
divid
multipl
function
subset
basi
cytokin
secret
depend
microenviron
activ
antigen
concanavalin
liver
mous
inflamm
model
cell
recruit
sinusoid
mediat
integrin
interact
wherea
cell
use
effector
cell
regulatori
treg
cell
found
liver
express
high
level
chemokin
receptor
use
migrat
across
subsequ
signal
determin
cell
local
within
liver
ccchemokin
receptor
cell
migrat
toward
ligand
ccchemokin
ligand
secret
bile
duct
wherea
treg
cell
respond
differ
chemokin
consequ
express
case
treg
cell
also
shown
use
distinct
combin
adhes
receptor
involv
stabilin
migrat
across
human
lsec
wherea
recruit
cell
mous
liver
primarili
depend
express
lsec
lesser
contribut
autoimmun
hepat
primari
scleros
cholang
psc
associ
ibd
lsec
present
chemokin
trigger
guthom
lymphocyt
interact
promot
recruit
mucos
distinct
mechan
migrat
across
lsec
probabl
influenc
epitheli
respons
tissu
stromal
cooper
interact
sever
cell
type
sinusoid
instanc
model
hbv
infect
effector
cell
shown
arrest
sinusoid
interact
platelet
adher
sinusoid
surfac
via
hyaluronandepend
subsequ
cell
crawl
along
sinusoid
probe
lsec
fenestra
viral
antigen
present
underli
hepatocyt
antigen
recognit
consequ
probe
behaviour
led
effector
function
diapedesisindepend
process
human
model
cytomegaloviru
cmv
infect
lsec
led
recruit
effector
cell
activ
treg
cell
lymphocyt
functionassoci
antigen
depend
studi
cmvinfect
human
lsec
upregul
intercellular
junction
effector
cell
recruit
interact
ligand
cell
contribut
cell
activ
although
b
cell
present
substanti
number
chronic
inflam
liver
tissu
molecular
mechan
regul
recruit
blood
hepat
tissu
poorli
understood
group
demonstr
b
cell
recruit
across
human
lsec
flow
initi
mediat
captur
follow
limit
intravascular
crawl
distinct
method
cell
interestingli
receptor
involv
transmigr
b
cell
includ
stabilin
also
involv
treg
cell
transmigr
across
lsec
neutrophil
one
earliest
immun
cell
recruit
site
tissu
injuri
also
recruit
liver
via
hepat
origin
thought
migrat
mediat
simpl
physic
trap
within
narrow
sinusoid
channel
work
mcdonald
et
implic
complex
multistep
recruit
process
involv
interact
sinusoid
hyaluronan
neutrophil
surfac
wherea
neutrophil
interact
postsinusoid
venul
follow
convent
roll
mediat
selectin
integrinmedi
adhes
found
case
sinusoid
major
neutrophil
extravas
occur
found
hyaluronan
highli
express
liver
sinusoid
mediat
recruit
neutrophil
respons
lp
challeng
interact
depend
hyaluronan
bind
rather
hyaluronan
receptor
receptor
hyaluronanmedi
motil
rhamm
also
known
hmmr
studi
publish
also
highlight
import
tlr
neutrophil
recruit
signal
particular
promot
product
chemokin
known
mediat
neutrophil
migrat
liver
macrophag
acut
chronic
mous
model
liver
addit
activ
resid
kc
monocyt
macrophag
also
recruit
liver
circul
inflamm
respons
injuri
kc
yolk
sacderiv
tissu
macrophag
found
within
hepat
sinusoid
immobil
probe
environ
respons
liver
injuri
also
includ
influx
monocyt
major
role
regul
inflamm
regener
repair
furthermor
acut
liver
injuri
associ
initi
influx
transcript
factor
periton
macrophag
enter
directli
mesothelium
process
depend
dangerassoci
molecular
pattern
damp
molecul
entri
follow
recruit
monocyt
subsequ
recruit
signal
govern
monocyt
migrat
sinusoid
less
well
character
sever
key
factor
determin
domin
chemokin
interact
mediat
migrat
monocyt
across
lsec
receptor
bind
ligand
ligand
one
transmembran
chemokin
express
restrict
bile
duct
normal
liver
yet
protein
express
high
level
inflam
sinusoid
studi
also
contribut
adhes
transendotheli
migrat
monocyt
across
lsec
accumul
monocyt
report
inflammatori
liver
diseas
due
part
preferenti
migrat
subset
across
lsec
compar
monocyt
known
undergo
phenomenon
bidirect
movement
across
endothelium
involv
revers
migrat
migratori
behaviour
confirm
lsec
might
mark
effect
fate
monocyt
outcom
liver
injuri
monocyt
subset
undergo
revers
transmigr
predominantli
proinflammatori
monocyt
contrast
remain
subendotheli
space
antiinflammatori
monocyt
suppress
cell
promot
endotoxin
although
focus
leukocyt
interact
lsec
crosstalk
lsec
liver
cell
popul
also
influenc
progress
chronic
inflammatori
liver
diseas
kc
found
within
hepat
sinusoid
close
associ
lsec
also
equip
sens
tissu
injuri
infect
toxin
releas
damp
pathogenassoci
molecular
pattern
trigger
inflammasom
pathway
inflammasom
activ
key
step
progress
parenchym
liver
injuri
alcohol
liver
diseas
releas
danger
signal
damag
hepatocyt
stimul
releas
proinflammatori
mediat
despit
poor
understand
crosstalk
lsec
kc
releas
mediat
probabl
influenc
lsec
phenotyp
activ
lead
subsequ
leukocyt
furthermor
kc
promot
lsec
capillar
wherebi
lsec
morpholog
becom
vascular
capillari
like
loss
fenestr
format
characterist
basement
cell
type
popul
sinusoid
hepat
stellat
cell
hsc
posit
within
space
diss
central
role
hsc
extracellular
matrix
product
chronic
liver
diseas
well
known
lsec
play
import
role
maintain
quiescenc
hsc
abil
lost
capillar
lsec
permit
hsc
activ
activ
liver
myofibroblast
deriv
predominantli
hsc
also
role
subsequ
migrat
posit
lymphocyt
follow
recruit
lsec
process
mediat
distinct
combin
cytokin
includ
vegf
chemokin
releas
lsec
also
key
role
maintain
hepatocyt
homeostasi
lsec
fenestr
enabl
bidirect
transport
metabolit
circul
liver
lsec
also
facilit
interact
circul
cell
hepatocyt
allow
cell
extend
cell
surfac
protrus
lsec
chronic
liver
injuri
microparticl
releas
hepatocyt
leukocyt
lsec
provid
anoth
rout
paracrin
factor
releas
hepatocyt
influenc
express
adhes
molecul
overli
lsec
promot
recruit
flow
lymphocyt
mechan
might
particularli
import
liver
cancer
malign
transform
hepatocyt
enhanc
abil
secret
chemokin
upregul
express
cocultur
work
group
demonstr
factor
secret
hepatoma
cell
upregul
express
lsec
promot
recruit
evid
present
highlight
crucial
role
play
lsec
regul
inflammatori
respons
liver
injuri
import
make
molecul
express
attract
therapeut
target
inflammatori
liver
good
studi
confirm
inhibit
enzymat
activ
antibodi
blockad
adhes
function
reduc
hepat
inflamm
fibrosi
mous
liver
injuri
work
led
clinic
trial
human
antibodi
current
underway
buteo
patient
psc
chemokin
adhes
molecul
express
inflam
lsec
also
potenti
target
antiinflammatori
therapi
liver
diseas
exampl
patient
pbc
treat
human
monoclon
antibodi
interestingli
high
product
rate
inflam
liver
made
difficult
achiev
sustain
neutral
chemokin
vivo
despit
evid
antibodi
could
remov
chemokin
sinusoid
endotheli
bed
although
drug
welltoler
demonstr
immunolog
chang
overal
result
thu
therapi
direct
chemokin
receptor
might
merit
evid
earli
trial
use
dual
antagonist
cenicriviroc
patient
nash
suggest
treatment
induc
persist
also
strong
rational
target
guttrop
chemokin
patient
liver
diseas
associ
ibd
particular
relev
psc
progress
biliari
diseas
associ
ibd
patient
affect
patient
ibd
particularli
physiolog
condit
express
absent
liver
psc
protein
detect
hepat
endothelium
support
aberr
recruit
effector
lymphocyt
gut
clinic
trial
current
consid
target
pathway
psc
use
antibodi
develop
treat
ibd
tolerogen
capabl
lsec
also
target
therapeut
nanoparticl
load
autoantigen
target
lsec
consequ
potent
scaveng
capabl
abil
lsec
take
molecul
use
scaveng
receptor
excel
way
potenti
target
rang
therapi
liver
present
deliv
autoantigen
lsec
naiv
cell
result
gener
autoantigenspecif
regulatori
cell
suppress
system
well
local
autoimmun
respons
strategi
could
appli
wide
rang
autoimmun
allerg
target
lsec
stabilin
stabilin
nanoparticlebas
suggest
way
deliv
local
treatment
manag
rang
condit
includ
injuri
specif
type
injuri
follow
liver
surgeri
transplant
biphas
process
involv
hypoxia
follow
restor
blood
flow
reoxygen
nafld
similarli
blockad
lsectin
relat
molecul
lsign
shown
reduc
metastasi
colon
cancer
cell
liver
via
impair
interact
lsec
mous
cirrhosi
chronic
hepat
lsec
undergo
process
associ
loss
upregul
loss
number
fenestr
per
endotheli
cell
decreas
also
phenotyp
chang
govern
chang
might
imped
transfer
materi
parenchyma
contribut
region
hepatocyt
hypoxia
capillar
mechanist
link
develop
chronic
inflammatori
diseas
rodent
model
associ
enhanc
antigen
present
cytotox
cell
prime
nash
capillar
preced
contribut
transit
simpl
steatosi
chang
occur
lsec
respons
chronic
inflamm
also
affect
angiogen
pathway
neoangiogenesi
key
featur
chronic
liver
diseas
major
neovessel
aris
portal
vein
branch
close
associ
area
key
initi
step
capillar
lsec
lead
increas
hepatocyt
hypoxia
subsequ
releas
proangiogen
lsec
respons
contextspecif
exampl
acut
injuri
induc
express
regen
respons
wherea
chronic
injuri
lead
induct
hsc
prolifer
injuri
lsec
develop
proinflammatori
prothrombot
phenotyp
associ
chang
directli
link
neutrophil
releas
lsec
injuri
trigger
releas
neutrophil
extracellular
trap
exacerb
acut
hepat
chronic
injuri
chang
endotheli
phenotyp
accompani
capillar
preced
fibrosi
link
alter
signal
via
hedgehog
gene
lead
vasoconstrict
increas
intrahepat
vascular
resist
owe
reduc
nitric
oxid
product
tumour
progress
hepatocellular
carcinoma
associ
chang
phenotyp
peritumour
lsec
increas
product
angiogen
factor
includ
chang
lsec
therefor
present
opportun
therapeut
intervent
exampl
pharmacolog
therapi
form
solubl
guanyl
cyclas
activ
restor
fenestr
link
fibrosi
regress
rodent
might
also
possibl
use
cellular
reprogram
restor
differenti
phenotyp
lsec
promot
fibrosi
similarli
therapi
restor
normal
hedgehog
signal
promot
regress
capillar
reappear
fenestr
suggest
potenti
pathway
revers
fibrosi
restor
lipid
howev
studi
test
cessat
vegfbas
cancer
therapi
also
highlight
import
develop
fenestr
context
metastasi
go
way
explain
poor
perform
strategi
use
antivegf
drug
cancer
treatment
withdraw
antivegf
antibodi
therapi
associ
develop
hyperpolar
lsec
promot
hepat
thu
lowdos
nonstop
antiangiogen
therapi
might
present
futur
solut
minim
effect
sinusoid
endotheli
cell
complex
interrel
role
mainten
liver
homeostasi
implic
driver
inflamm
fibrogenesi
liver
diseas
uniqu
posit
phenotyp
function
make
attract
candid
organspecif
therapi
like
therapi
target
cell
test
futur
new
treatment
reduc
liver
injuri
inflamm
prevent
revers
fibrogenesi
absenc
licenc
antifibrot
therapi
strategi
maintain
differenti
lsec
inhibit
abil
recruit
harm
proinflammatori
leukocyt
select
orchestr
immun
cell
traffic
might
provid
vital
tool
halt
increas
mortal
link
chronic
liver
failur
